EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹5.82 Cr | ₹0.00 Cr | ₹-0.38 Cr | ₹-1.01 Cr | ₹-0.34 Cr |
What is the latest Net Cash Inflow / Outflow ratio of EVEREST ORGANICS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹5.82 Cr |
| Mar2024 | ₹0.00 Cr |
| Mar2023 | ₹-0.38 Cr |
| Mar2022 | ₹-1.01 Cr |
| Mar2021 | ₹-0.34 Cr |
How is Net Cash Inflow / Outflow of EVEREST ORGANICS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.82 Cr | Positive | |
| Mar2024 | ₹0.00 Cr | Negative | |
| Mar2023 | ₹-0.38 Cr | Negative | |
| Mar2022 | ₹-1.01 Cr | Negative | |
| Mar2021 | ₹-0.34 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹242.2 Cr | -7.5% | -2.4% | -19.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -7.5% |
-2.4% |
-19.2% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses